Role Of Self-monitoring of Blood Glucose and Intensive Education in Patients With Type 2 Diabetes Not Receiving Insulin
- Conditions
- Type 2 Diabetes
- Registration Number
- NCT01176149
- Lead Sponsor
- Consorzio Mario Negri Sud
- Brief Summary
The aim of this pilot study is to evaluate the validity and feasibility of an educational approach involving nurses, combined with SMBG, aimed at lifestyle modification and timely changes in therapy, when needed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 62
- Patients with Type 2 diabetes (known diabetes or new diagnosis) seen for the first time in the diabetes outpatient clinic;
- Patients on treatment with OHA monotherapy (i.e. metformin alone or sulphonylureas alone or TZDs alone);
- No need for insulin treatment;
- Male and female patients, aged between 45-75 years;
- Hba1c values between 7% and 9% included (considering a value of 6.0% as the upper limit of normal value)
- No experience of self monitoring of blood glucose in the previous 12 months (SMBG performed with a frequency of < 1 times/week)
- Ability and willingness to comply with all study requirements
- Signature of consent form
- Patients incapable to perform SMBG
- Patients needing insulin or multiple OHA association therapy
- Patients needing a regular use of SMBG (e.g. frequent hypoglycemic episodes)
- Diabetes care not exclusively managed by diabetic clinics
- Patients with serious underlying medical or psychiatric condition
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Improvement of metabolic control Aim of this study is to evaluate the efficacy of Self Monitoring Blood Glucose and Intensive Education in terms of improvement of metabolic control expressed as HbA1c levels after 6 months.
- Secondary Outcome Measures
Name Time Method Reduction in prandial Blood Glucose excursions Percentage of patients needing therapy modifications Percentage of patients reaching target HbA1c (i.e. <7.0%)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Consorzio Mario Negri Sud
🇮🇹Santa Maria Imbaro, Chieti, Italy
Consorzio Mario Negri Sud🇮🇹Santa Maria Imbaro, Chieti, Italy